Posts Tagged ‘from’

Mesa, AZ (PRWEB) April 20, 2006

Salt and additive-free spices are nothing new. What is new and special about The Herb Lady’s line is their fresh and appetizing appeal. Blended in small batches to ensure their freshness, these dried herbs and spices bring incredible flavor to all foods. And they only contain herbs and spices. No flowing agents, starches, fillers, sugars or chemicals are used in the blends. And all are salt- free.

“Folks can always add salt,” explains Catherine, The Herb Lady, “but you can’t remove it.” “I let customers know they can take our blends and make their own seasoned salt, if they care to. The point is they control the ingredients and the amount of salt in their food.”

The focus is flavor. “If you had to cook chicken or tofu every night,” asks The Herb Lady. “Could you make it a ‘wow, this is great,’ instead of ‘not ______ again!” Dried spices with fresh and appealing combinations put the ‘wow’ into cooking. The blends from Herbs 2 U make creating tasty meals easy.

These spices arose out of The Herb Lady’s use of her own fresh garden herbs and spices. Since many cooks do not have access to fresh herbs, the idea of creating a line of dried spices using recipes developed by The Herb Lady, was born.

The first three blends will be introduced April 29, 2006, at the Granola’s store located at 5055 West Ray Road, Chandler, Arizona 85226, from 11 a.m. to 1 p.m. For information call: 480/940- 1571.

Catherine, The Herb Lady teaches and writes on growing and cooking with herbs, flowers and other edibles in the Valley of the Sun. Class and event schedule is available at the website www.herbs2u.net, click on “learn” for details.

The Herb Lady, author of the book “Edible Landscaping in the Desert Southwest: Wheelbarrow to Plate,” is also a regular guest on Ed Phillip’s streaming radio www.azalmanac.com, and her column appears monthly in the online edition of the East Valley Tribune.

Herbs 2 U was founded to educate and inform folks on gardening with herbs, edible flowers and other edible plants, and then bringing those useful and flavorful plants into the kitchen and creating mouth-watering meals.

Granola’s Natural Market is a place that provides a fun and educational experience for customers seeking a healthier lifestyle and want to feel better through nutrition. At Granola’s they really care about what you put in your body. They work hard to provide their customers with a healthy mix of solid nutrition, important information, and great people. “Granola’s – Your Neighborhood Health Nuts,” is their slogan.

In addition to The Herb Lady’s spices, Granola’s offers a fresh juice bar, fresh produce, including baby vegetables from Maya’s at The Farm at South Mountain, other grocery foods, books, and beauty and health aids.

###

Lot of 10 “LOVE PENDANT” an ANION ENERGY SCALAR ENERGY ZERO POINT ENERGY PENDANT – A 2 PENDANT SET FROM QBP & YANCHEN

• Quantum BioPhysics Product is Guaranteed Radioactive Free
• Our pendant has fm 3000 to 3500 neg ions
• Neg Ions – the refreshing smell after a lightning storm – Longitudinal Energy
• Proprietary Product of Quantum BioPhysics – all other sellers sell FAKE KNOCK OFFS
• Jewelry, but yet it helps to improve your health

QBP and Yanchen have teamed to bring you the “LOVE PENDANT”. This is a HIS and HER set that has no match. Each Quantum BioPhysics Anion and Scalar Energy Pendant is a wearable handmade jewelry made from special Japanese volcanic lava containing over 70 Natural Cosmic Energy Minerals, manufactured in an ISO Certified factory processed under extreme temperature before it is coagulated to form bio-ceramics under low temperature treatment & structurally bonded together at a molecular level. The Quan

Price:

Related Alternate Medicine Products


xml:lang=”en” lang=”en” xmlns=”http://www.w3.org/1999/xhtml”>

International Malaria Research Consortium Combines Technologies and Expertise From Two Continents to Tackle Deadly Disease

Toronto, ON (Vocus) October 27, 2010

Research teams from three academic institutions and two private sector companies on two continents have come together to form the “International Malaria Research Consortium for the development of novel classes of antimalarials” ,(the “Consortium”) a bold initiative to develop novel classes of drugs against malaria, a deadly disease in desperate need of new treatments.

Each of the Consortium’s five partners brings unique capabilities spanning the spectrum from academic research to commercial development, and significantly – their existing technologies to the table. Through an extensive program design process, the parties hit upon unique combinations of these existing technologies that, combined with new drugs to be developed under the program, represent entirely new approaches to treating and potentially even eradicating this disease.

‘It was a fascinating process to see different organizations with deep knowledge in their individual fields coming together and combining this knowledge to create innovative new approaches to the treatment of this disease’’ – Prof. Virander Chauhan, Director, International Center for Genetic Engineering and Biotechnology-New Delhi

“Creative leverage” is a term that comes to mind in describing this program. Iin addition to developing new therapeutics, we are also bringing together existing technologies developed by the partners and combining them in new ways such that one will have the potential to boost the effectiveness of another.” – Dr. Lakshmi P. Kotra, Director, Center for Molecular Design and Preformulations, University Health Network and University of Toronto.

In a field that has seen very few new drugs introduced in the past 30 years, and where most of these drugs have lost effectiveness due to the emergence of drug resistant malaria strains, this program endeavors to develop entirely new classes of drugs, and furthermore will seek to develop drugs that, by their design, will hinder the emergence of drug resistance.

With funding from the International Science and Technology Partnerships Canada Inc. (ISTPCanada) and the Department of Biotechnology (DBT) of the Government of India, these new therapies will be developed and refined. Led by the site directors of each partner, Lakshmi Kotra at University Health Network/University of Toronto (Consortium lead in Canada), David Bell at Therapure Biopharma, Jitendra Verma at Lifecare Innovations, Asif Mohammed at the International Center for Genetic Engineering and Biotechnology (Consortium lead in India), and R. Mahesh at Birla Institute of Technology and Science, this program brings together a dynamic and talented groups of world-class scientists for a common cause of advancing basic research discoveries to preclinical development. This consortium brings their combined drug development expertise to the discovery and development of new compounds against targets in the parasite that causes malaria.

Current projects include the development of drugs against three malaria targets that the academic groups have researched extensively. This research is combined with the state-of-the-art tools and expertise in computer modeling, medicinal chemistry, nanoformulations and drug conjugation technologies from the consortium partners to advance potential drugs into IND enabling studies. The consortium has already made excellent progress since its activities started in April, 2010 and looking to expand the scope of the efforts with additional partners to advance the mission to develop clinically viable new antimalarials.

One example of this technology combination process is embodied in an objective to treat a form of malaria that resides in the liver. This form of the disease can re-emerge months or years after the initial infection to cause new illnesses in that individual. Additionally this form of the disease can re-introduce malaria into local populations where it had previously been eliminated – frustrating permanent eradication efforts. To tackle this problem the program will combine new drugs developed with existing technologies designed to deliver drugs to the liver in an effective form.

Other technology harnessed under the program will allow antimalarial drugs to be released slowly over long periods of time. This slow release gives the potential for a “one pill cure” , a long sought after goal in anti-malarial drug development programs as it would allow the most effective utilization of often limited medical resources.

Malaria is one of humanities most devastating illnesses with an estimated 247 million cases worldwide in 2008 and almost one million deaths, mostly among children. In Africa a child dies every 45 seconds of Malaria and the disease accounts for 20% of all childhood deaths. Furthermore drug resistance is steadily undermining the effectiveness of existing treatments – driving the need for new therapies.

About Therapure Biopharma

Therapure Biopharma Inc. is an integrated biopharmaceutical company that develops, manufactures, purifies, and packages therapeutic proteins. Therapure Biopharma is also a specialist in therapies derived from hemoglobin, a blood protein. As a contract development and manufacturing organization (CDMO)

Therapure Biopharma applies scientific, manufacturing, and downstream purification expertise with an intimate understanding of advanced biology, complex proteins, and regulatory processes to develop effective and innovative solutions to advance products from discovery to market.

About University Health Network

University Health Network consists of Toronto General, Toronto Western and Princess Margaret Hospitals. The scope of research and complexity of cases at University Health Network has made it a national and international source for discovery, education and patient care. It has the largest hospital-based research program in Canada, with major research in cardiology, transplantation, neurosciences, oncology, surgical innovation, infectious diseases, and genomic medicine. University Health Network is a research and teaching hospital affiliated with the University of Toronto.

About International Centre for Genetic Engineering Biotechnology (ICGEB)

The ICGEB is an autonomous, intergovernmental organization with its headquarters in Trieste, Italy and two other components in New Delhi, India and Cape Town, South Africa; in addition, ICGEB currently has 57 full Member countries. The ICGEB provides a scientific and educational environment of the highest standard and conducts innovative research in life sciences for the benefit of developing countries. It strengthens the research capability of its members through training and funding programs and advisory services and represents a comprehensive approach to promoting biotechnology internationally.

About Birla Institute of Technology & Science (BITS)

The Birla Institute of Technology & Science (BITS), Pilani is an all-India Institute for Higher Education. The research group at BITS has expertise in synthetic chemistry and drug delivery areas with a strong track record of research in medicinal chemistry and drug discovery related areas.

About Lifecare Innovations

Lifecare Innovations is an R&D intensive company specializing in controlled release pharmaceuticals employing an array of novel drug delivery technologie.. Lifecare Innovations is engaged in the development of number of these controlled release drugs in collaboration with national institutions. These are under various stages of development. Predominant among these are a range of antifungals. In addition, in-house developments for commercialization of technologies have led to the successful launch of several drugs in the market by Lifecare Innovations.

Company Contacts:

Thomas Wellner, President and CEO

Therapure Biopharma Inc.

+1 905 286-6204

http://www.therapurebio.com

###

©Copyright 1997-2010, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

More Alternate Medicine Press Releases


xml:lang=”en” lang=”en” xmlns=”http://www.w3.org/1999/xhtml”>

Award-winning Tea Infuser from The Tea Spot Gains National Distribution in Sur La Table Stores

Loose Tea Infuser from The Tea Spot – The Tuffy Steeper

Boulder, CO (Vocus) October 19, 2010

The Tuffy Tea Steeper is an affordable and easy to use tool for people looking to discover loose leaf tea, or for tea aficionados looking to take their leaf tea steeping on the road. It is now being introduced in Sur La Table stores nationwide at a retail price of .95.

The Tuffy Steeper is a revolutionary portable silicone tea infuser. This loose tea infuser is a versatile kitchen gadget designed for steeping loose leaf tea, coarse ground coffee, and herbs, both at home and on the go. Designed to fit most cups, mugs and teapots, it is now available in six bright colors, including two new vibrant shades – Strawberry and Key Lime – perfect for the upcoming holiday season.

The Tuffy Tea Steeper is the entry level Patent-Pending loose leaf tea infuser in The Tea Spot’s line of Steepware®. The Tea Spot was awarded the 2009 Gear of the Year Award for the Tuffy Steeper by Shape You, Home of the Gear of Year Awards™. This durable silicone tea infuser weighs only 2 oz., and folds down to less than an inch tall with a 3-inch diameter, making it ideal for travel and camping. It is dishwasher safe.

Steepware® designs are The Tea Spot’s functionally designed tools that bring convenience to the quality and integrity of steeping loose leaf tea. Steepware® is a new category in housewares that infuses ancient tea traditions with modern technology and design. The Tea Spot’s Steepware® line currently includes Steeping Cups, Tea Mugs, and the Dripless Teapot – all handcrafted using high quality lead–free ceramics. The Tea Spot will continue to bring new products to this line to enhance the simplicity of steeping great loose leaf tea.

Jessica Burtenshaw, The Tea Spot’s Director of Development, announced “Being from the West Coast, I grew up going to Sur La Table stores with my father, a weekend warrior chef and avid collector of cooking gadgets. Naturally, I’m ecstatic that our latest Steepware® innovation is going to be carried at Sur La Table – the gourmet cook’s paradise.”

The first Sur La Table store opened in Seattle’s Pike Place Market in 1972 selling hard-to-find kitchenware imported from France. Since then the company has expanded to more than 75 stores nationwide, a direct-mail business distributing millions of catalogs each year, an e-commerce site, a gift registry, and a cooking class program. Sur La Table continues to carry many of the same products from France that it carried when it opened, but now offers tools from around the world to prepare any cuisine. Sur La Table remains committed to its roots by continuing to provide exceptional customer service and a broad assortment of premium-quality products. Sur La Table headquarters are located in Seattle, Washington.

The Tea Spot is a certified woman-owned and operated business producing proprietary products for loose leaf tea. Patented tea infuser products are marketed under the Steepware® trademark. They also offer a line of exclusive, organic, and Fair-Trade Certified™ leaf teas. Based in Boulder, Colorado, the company was founded in 2004 by Maria Uspenski, a cancer survivor drawn to the health benefits of green leaf tea during her recovery. She set forth to modernize the loose tea experience, making it an everyday luxury. Her message is simple and powerful: leaf tea in its freshest form renders incredible flavor, unmatched health benefits, and is eco-friendly. The company ensures that its teaware upholds clean, sustainable and fair manufacturing standards. The Tea Spot’s model of social entrepreneurship incorporates a culture of giving as it grows: Ten percent of every sale made is donated in-kind to cancer and community wellness programs.

###

Attachments

©Copyright 1997-2010, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Related Herbs Press Releases